First Time Loading...
N

Nuoncology Labs Inc
OTC:NLAB

Watchlist Manager
Nuoncology Labs Inc
OTC:NLAB
Watchlist
Price: 297 USD Market Closed
Updated: Apr 27, 2024
Section:
 

Intrinsic Value

NLAB price has not been updated for more than 6 months. This may indicate that the stock has been delisted.

NuOncology Labs, Inc. is a non-operating company. [ Read More ]

There is not enough data to reliably calculate the intrinsic value of NLAB.

Key Points:
NLAB Intrinsic Value
Base Case
Not Available
N
Base Case Scenario
What is intrinsic value?

Fundamental Analysis

Beta
Ask me anything about
Nuoncology Labs Inc

What unique competitive advantages
does Nuoncology Labs Inc hold over its rivals?

What risks and challenges
does Nuoncology Labs Inc face in the near future?

Provide an overview of the primary business activities
of Nuoncology Labs Inc.

Show all valuation multiples
for Nuoncology Labs Inc.

Provide an overview of the primary business activities
of Nuoncology Labs Inc.

What unique competitive advantages
does Nuoncology Labs Inc hold over its rivals?

What risks and challenges
does Nuoncology Labs Inc face in the near future?

Show all valuation multiples
for Nuoncology Labs Inc.

Provide P/S
for Nuoncology Labs Inc.

Provide P/E
for Nuoncology Labs Inc.

Provide P/OCF
for Nuoncology Labs Inc.

Provide P/FCFE
for Nuoncology Labs Inc.

Provide P/B
for Nuoncology Labs Inc.

Provide EV/S
for Nuoncology Labs Inc.

Provide EV/GP
for Nuoncology Labs Inc.

Provide EV/EBITDA
for Nuoncology Labs Inc.

Provide EV/EBIT
for Nuoncology Labs Inc.

Provide EV/OCF
for Nuoncology Labs Inc.

Provide EV/FCFF
for Nuoncology Labs Inc.

Provide EV/IC
for Nuoncology Labs Inc.

Compare the intrinsic valuations
of Nuoncology Labs Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Nuoncology Labs Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Nuoncology Labs Inc compared to its peers.

Compare the P/E ratios
of Nuoncology Labs Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Nuoncology Labs Inc with its peers.

Analyze the financial leverage
of Nuoncology Labs Inc compared to its main competitors.

Show all profitability ratios
for Nuoncology Labs Inc.

Provide ROE
for Nuoncology Labs Inc.

Provide ROA
for Nuoncology Labs Inc.

Provide ROIC
for Nuoncology Labs Inc.

Provide ROCE
for Nuoncology Labs Inc.

Provide Gross Margin
for Nuoncology Labs Inc.

Provide Operating Margin
for Nuoncology Labs Inc.

Provide Net Margin
for Nuoncology Labs Inc.

Provide FCF Margin
for Nuoncology Labs Inc.

Show all solvency ratios
for Nuoncology Labs Inc.

Provide D/E Ratio
for Nuoncology Labs Inc.

Provide D/A Ratio
for Nuoncology Labs Inc.

Provide Interest Coverage Ratio
for Nuoncology Labs Inc.

Provide Altman Z-Score Ratio
for Nuoncology Labs Inc.

Provide Quick Ratio
for Nuoncology Labs Inc.

Provide Current Ratio
for Nuoncology Labs Inc.

Provide Cash Ratio
for Nuoncology Labs Inc.

What is the historical Revenue growth
over the last 5 years for Nuoncology Labs Inc?

What is the historical Net Income growth
over the last 5 years for Nuoncology Labs Inc?

What is the current Free Cash Flow
of Nuoncology Labs Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Nuoncology Labs Inc.

Popular Strategic Analysis Valuation Peer Analysis Profitability Solvency Financials
Financials
Revenue
Operating Income
Net Income
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

Balance Sheet Decomposition
Nuoncology Labs Inc

0
Assets
0
Liabilities
0
Assets
0
Liabilities
Efficiency

Earnings Waterfall
Nuoncology Labs Inc

Revenue
0 USD
Operating Expenses
-29.2k USD
Operating Income
-29.2k USD
Other Expenses
0 USD
Net Income
-29.2k USD
Operating Margin
Net Margin
FCF Margin
ROE
ROA
ROIC
ROCE

Free Cash Flow Analysis
Nuoncology Labs Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

NLAB Profitability Score
Profitability Due Diligence

Nuoncology Labs Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Negative Free Cash Flow
Negative Operating Income
Negative Net Income
47/100
Profitability
Score

Nuoncology Labs Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

NLAB Solvency Score
Solvency Due Diligence

Nuoncology Labs Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

50/100
Solvency
Score

Nuoncology Labs Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NLAB Price Targets Summary
Nuoncology Labs Inc

There are no price targets for NLAB.
NLAB Lowest Forecast
Wall Street Target
Not Available
NLAB Average Forecast
Wall Street Target
Not Available
NLAB Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

NLAB Price
Nuoncology Labs Inc

1M 1M
-
6M 6M
-
1Y 1Y
-
3Y 3Y
+1 263 730%
5Y 5Y
+4 868 752%
10Y 10Y
+6 456 422%
Annual Price Range
297
52w Low
N/A
52w High
N/A
Price Metrics
Average Annual Return 86.7%
Standard Deviation of Annual Returns 192.16%
Max Drawdown -100%
Shares Statistics
Market Capitalization 29.3B USD
Shares Outstanding 98 783 696
Percentage of Shares Shorted
N/A

NLAB Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Nuoncology Labs Inc

Country

United States of America

Industry

N/A

Market Cap

29.3B USD

Dividend Yield

0%

Description

NuOncology Labs, Inc. is a non-operating company. The company is headquartered in Scottsdale, Arizona. The company went IPO on 2001-07-11. The Company’s business plan includes acquisitions of operating companies. The firm also seeks businesses opportunities with entities having established operating histories. The firm is not generated any revenues.

Contact

ARIZONA
Scottsdale
Po Box 26496
+16027938058.0

IPO

2001-07-11

Employees

7

Officers

CEO, CFO, Pres, Sec., Treasurer, Director
Dr. Rhonda Keaveney J.D.

See Also

Summary
NLAB intrinsic value, competitors valuation, and company profile.
DCF Valuation
NLAB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NLAB stock valuation using valuation multiples.
Wall Street Estimates
NLAB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NLAB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 131,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.